Thryv Therapeutics to Present at Key Healthcare Conferences
Thryv Therapeutics Inc., a clinical-stage biotechnology company focusing on innovative therapies for cardiovascular diseases, is excited to announce its participation in four significant healthcare investor conferences in the near future. These events will allow the company to share vital updates regarding their advancements in precision medicine, a field that promises to enhance treatment methodologies significantly.
Stifel Healthcare Conference
The Stifel Healthcare Conference is set to feature various formats, including presentations and one-on-one investor meetings. Thryv Therapeutics will present on a notable day, showcasing its cutting-edge approach to treating conditions such as Long QT Syndrome, heart failure, and atrial fibrillation. The company aims to engage directly with investors to discuss its strategy and scientific developments.
Conference Details
The presentation is scheduled for Monday, from 1:50 p.m. to 2:20 p.m. ET. This key event will be held at Lotte New York Palace Hotel. The Thryv team will also be available throughout the day for personalized meetings, allowing investors to delve deeper into the company’s pipeline and innovations.
Jefferies London Healthcare Conference
Following the Stifel event, Thryv Therapeutics will participate in the prestigious Jefferies London Healthcare Conference. Taking place over three days, from November 19 to 21, this conference represents an excellent venue for showcasing Thryv's advancement in the global arena.
Meeting Arrangements
Investors interested in arranging a meeting at this conference are encouraged to reach out directly for more information and scheduling.
Piper Sandler Annual Healthcare Conference
The Piper Sandler 36th Annual Healthcare Conference will offer Thryv Therapeutics opportunities for individual meetings with critical investors and stakeholders. This event is slated for December 3 to 5 in New York City. As the company continues to progress in innovative treatments, this conference will be a chance to reinforce Thryv's commitment to improving patient outcomes.
Connections and Discussions
Attendees can anticipate insightful discussions on how Thryv’s precision medicine strategies are developing, and how these breakthroughs can benefit the broader healthcare landscape.
Wells Fargo Virtual Private Biotech Symposium
Wrapping up the series of conferences, Thryv will also participate in the Wells Fargo Virtual Private Biotech Symposium on December 12. This event mainly encompasses one-on-one investor meetings, facilitating focused discussions on the company's future.
Engagement Opportunities
The virtual format allows for flexibility, enabling Thryv Therapeutics to connect with investors in a convenient setting. Interested parties can coordinate meetings to explore Thryv’s strategic visions and innovations.
About Thryv Therapeutics Inc.
Thryv Therapeutics Inc., located in Montreal, Quebec, Canada, is dedicated to developing impactful therapies through precision medicine. The company is particularly focused on creating effective inhibitors for serum glucocorticoid inducible kinase 1 (SGK1), targeting cardiovascular conditions that significantly affect patients' lives.
Frequently Asked Questions
What is the focus of Thryv Therapeutics?
Thryv Therapeutics specializes in innovative therapies for cardiovascular diseases, emphasizing precision medicine approaches.
When will Thryv participate in the Stifel Healthcare Conference?
The Stifel Healthcare Conference presentation is scheduled for November 18, from 1:50 p.m. to 2:20 p.m. ET.
Where will the Jefferies London Healthcare Conference take place?
The Jefferies London Healthcare Conference will occur from November 19 to 21, in London, UK.
What is the significance of the Piper Sandler Conference?
The Piper Sandler Conference is an opportunity for Thryv to engage in one-on-one meetings with investors to discuss its advanced therapeutics and future strategies.
How is Thryv planning to connect with investors?
Thryv Therapeutics is facilitating meetings during its conference presentations and through virtual attendance, enhancing investor engagement.
